Immunotherapy Patient Forum: 6 Reasons to Attend

27 October 2015 In Events

On November 7, the Melanoma Research Alliance is co-hosting a Patient Forum on Immunology with Global Resource for Advancing Cancer Education and the Society for Immunotherapy of Cancer. The event will be held at the National Harbor, near Washington, DC. Online registration is open through October 30.

Read More


A Father Shares His Family's Journey with Melanoma

By Skip Grinberg | 16 October 2015 In Melanoma Stories

In this guest blog post, Skip Grinberg shares his family's experience with melanoma and his drive to advance research. [caption id="attachment_1505" align="alignright" width="300"] Skip Grinberg and his extended family[/caption] Life can occasionally throw you a sharp-breaking curveball.

Read More


Melanoma and the Problem of Drug Resistance

8 October 2015 In Science

In 2002, researchers discovered a link between mutated BRAF genes and nearly half of all melanoma tumors. Since then, BRAF inhibitors—drugs that target mutated BRAF—have become a leading go-to weapon in the battle against melanoma. Their job is to cut off signals sent by altered BRAF that promote the rapid...

Read More


Researcher Q&A: Dr. Niroshana Anandasabapathy

30 September 2015 In Science

In our latest research feature, we spoke with Niroshana Anandasabapathy of Brigham and Women’s Hospital, who is the recipient of an MRA Young Investigator Award. Funded in collaboration with Brigham and Women’s Hospital, Dr. Anandasabapathy’s research is titled “Expanding immune-surveillance and immunotherapy of melanoma.” Here she explains more about her research.

Read More


The Latest on Skin Cancer Screenings

22 September 2015 In Science

To routinely screen for skin cancer or not to screen? That hot-button question still doesn’t have a solid answer. In 2009, the U.S. Preventive Services Task Force found insufficient evidence to recommend annual skin cancer screenings for all adults.

Read More


MRA Announces RFP for Translational Research

16 September 2015 In Science

MRA is pleased to announce a Request for Proposals (RFP) soliciting high-impact translational research from scientists and clinicians around the world. This RFP is for 2015-2016, with awards being announced in the spring of 2016. The RFP calls for ideas that have the potential to lead to near-term clinical application...

Read More


Researcher Q&A: Dr. Neil Ganem

2 September 2015 In Science

In an effort to share more about the work being done in the field of melanoma research, we are beginning a new feature on our blog to showcase some of our funded investigators. Today we’re talking with Neil Ganem, Ph.D., Assistant Professor of Pharmacology and Medicine at Boston University School of...

Read More


Immunotherapy for Melanoma: Where We Are

28 August 2015 In Science

As was reported last week, Former President Jimmy Carter has melanoma that has spread to other organs, and part of his treatment will include an immunotherapy drug. Immunotherapy is a term used to describe treatments that harness the body’s immune system to fight cancer cells.

Read More


What We Can Learn from President Carter’s Melanoma Diagnosis and Treatment

By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 21 August 2015 In Treatment

President Jimmy Carter revealed to the world his diagnosis with melanoma with both the grace and bravery that we may all aspire to in the face of such news. His melanoma presentation was a bit unusual and naturally confusing.

Read More


A Conversation with Board Member Jami Gertz

19 August 2015 In Allies & Partnerships

We're featuring an interview with MRA Board Member and actress Jami Gertz on our blog. This was repurposed, with permission, from the blog of our partners at Neiman Marcus. 

Read More


Login

×